CG
BMY icon

Curat Global’s Bristol-Myers Squibb BMY Stock Holding History

Curat Global’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Sell
2,723
-1,100
-29% -$63.2K 0.18% 88
2026
Q1 		$232K Buy
3,823
+595
+18% +$34.7K 0.23% 86
2025
Q4 		$174K Sell
3,228
-1,000
-24% -$48.1K 0.19% 97
2025
Q3 		$190K Hold
4,228
– – 0.18% 98
2025
Q2 		$196K Buy
4,228
+774
+22% +$38K 0.19% 99
2025
Q1 		$211K Buy
+3,454
New +$201K 0.26% 96

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Curat Global's BMY Position: Q2 2026 in Review

Curat Global reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, selling an estimated $63.2K and leaving 2,723 shares worth $220K. The position accounts for 0.18% of the portfolio, ranked #88.

Curat Global first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $232K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Curat Global held 2,723 shares of Bristol-Myers Squibb worth $220K as of Q2 2026.
  • Curat Global sold 1,100 Bristol-Myers Squibb shares in Q2 2026, an estimated $63.2K.
  • Bristol-Myers Squibb made up 0.18% of Curat Global's portfolio in Q2 2026, its #88 holding.
  • Curat Global first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
  • Curat Global's Bristol-Myers Squibb position peaked at $232K in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Curat Global's 13F filing for Q2 2026, filed 22 Jul 2026.